Childhood Cancers

Cancer comes with an awful storm, but the prisms of light can make it a little less worse.

Besponsa provides another — and potentially more effective — option outside of traditional chemotherapy for pediatric patients with relapsed or refractory B-ALL.

Musical play engages children with cancer, which relieves stress for them and their parents/caregivers, an expert said.

The investigational drug LSTA1 is being explored for the treatment of osteosarcoma, which starts in the bones and accounts for 2% of childhood cancers.

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.

Survivors of rhabdomyosarcoma may be at higher risk for poorer psychological outcomes, that radiation therapy and smoking may worsen.

The Food and Drug Administration approved Besponsa for pediatric patients aged 1 and older with relapsed or refractory CD22-positive, B-cell precursor ALL.

“Waiting” described the waiting room at Children’s Hospital to get my chemotherapy. “My Days” was a remembrance of the year I was diagnosed with leukemia.

A young girl once fought as hard as she could though cancer.

From International Childhood Cancer Day to an Ivory Coast soccer player making a victorious comeback after testicular cancer, here’s what is happening in the oncology space this week.

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews

New guidelines provide a framework for pediatric neuroblastoma treatment — as well as conversations families should have with their oncology teams.

From Broadway actor Jeff Gorti opening up about his childhood cancer experience to Brian Barczyk of The Reptarium dying, here’s what’s happening in the oncology space this week.

Recent research determined that two specific biomarkers may help predict and protect survivors of childhood cancer from heart risks, such as cardiomyopathy.

Children with cancer tended to feel less anxiety after undergoing four sessions of creative art therapy, recent research showed.

The Food and Drug Administration recently approved treatment for some patients with neuroblastoma, kidney cancer and bladder cancer. Elsewhere, a cancer vaccine made headlines for the treatment of patients with melanoma.

The Food and Drug Administration approved Iwilfin for high-risk neuroblastoma in adult and pediatric patients who previously had at least a partial response to a multiagent, modality therapy.

As Shannen Doherty revealed her cancer diagnoses and upcoming podcast and a woman with breast cancer completed her bucket list, here is what’s happening in the oncology space this week.

As part of its Speaking Out® video series, CURE® spoke with Dusty Joy Donaldson of LiveLung/The Dusty Joy Foundation and Lung Cancer Action Network about her lung cancer journey and the importance of scans.

From Dick Vitale to Make-A-Wish’s Miles Scott reveal that they are cancer free, here is what’s happening in the oncology space this week.

Charlene Wexler, the Chicago-based author of the Laughter and Tears series of novels, is an ovarian cancer survivor who now has skin cancer. She told CURE® about how her son’s death from leukemia led to her re-invention as a writer.

This expanded indication broadens the use of Rozlytrek for solid tumors to include children one month old, with the original approval in 2019 only including children one year and older.

A childhood cancer specialist discusses how oncology drug shortages may affect the treatment of children with cancer.

Laura Shinn and Jenna Cavalero, both former childhood patients of the Children’s Hospital of New Orleans, reflect on how their cancer journeys inform their work with patients today.

Ashton’s story starts with her. Our beautiful, big-hearted, kind girl.